Sarcoidosis Therapeutic Development and Pipeline Market Review H1 2015 Report Available at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds “Sarcoidosis – Pipeline Review, H1 2015” to its store. The report provides an overview of the Sarcoidosis’s therapeutic pipeline.

Sarcoidosis Therapeutic Pipeline Industry

Sarcoidosis Therapeutic Pipeline Industry

Past News Releases

RSS

Sarcoidosis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com

RnRMarketResearch.com adds “Sarcoidosis – Pipeline Review, H1 2015” to its store. The report provides an overview of the Sarcoidosis’s therapeutic pipeline.

The report “Sarcoidosis – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Sarcoidosis. Sarcoidosis is an interstitial lung disease, which is a large group of lung disorders that affect the tissues of the lungs and generally cause lung scarring. The symptoms of sarcoidosis include: Cough, Shortness of breath, Chest pain, Fatigue, Weakness, Fever and Weight loss. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/sarcoidosis-pipeline-review-h1-2015-market-report.html .

The report also reviews key players involved in the therapeutic development for Sarcoidosis and special features on late-stage and discontinued projects. Companies discussed in this Sarcoidosis – Pipeline Review, H1 2015 report include Celgene Corporation, FirstString Research, Inc., Johnson & Johnson, PharmaIN Corporation and Therametrics holding AG.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are apremilast, CC-220, eprodisate disodium, golimumab, PGC-VIP, Synthetic Peptide for Sarcoidosis and thymopentin. Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=314367 . (This is a premium report priced at US$2000 for a single user License.)

List of Tables
Number of Products under Development for Sarcoidosis, H1 2015 7
Number of Products under Development for Sarcoidosis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 10
Comparative Analysis by Early Stage Development, H1 2015 11
Products under Development by Companies, H1 2015 12
Sarcoidosis - Pipeline by Celgene Corporation, H1 2015 13
Sarcoidosis - Pipeline by FirstString Research, Inc., H1 2015 14
Sarcoidosis - Pipeline by Johnson & Johnson, H1 2015 15
Sarcoidosis - Pipeline by PharmaIN Corporation, H1 2015 16
Sarcoidosis - Pipeline by Therametrics holding AG, H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Stage and Target, H1 2015 20
Number of Products by Stage and Mechanism of Action, H1 2015 22
Number of Products by Stage and Route of Administration, H1 2015 24
Number of Products by Stage and Molecule Type, H1 2015 26
Sarcoidosis Therapeutics - Recent Pipeline Updates, H1 2015 40
Sarcoidosis - Dormant Projects, H1 2015 54
Sarcoidosis - Discontinued Products, H1 2015 55

List of Figures
Number of Products under Development for Sarcoidosis, H1 2015 7
Number of Products under Development for Sarcoidosis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 10
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Top 10 Targets, H1 2015 19
Number of Products by Stage and Top 10 Targets, H1 2015 20
Number of Products by Top 10 Mechanism of Actions, H1 2015 21
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Top 10 Routes of Administration, H1 2015 23
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 24
Number of Products by Top 10 Molecule Types, H1 2015 25
Number of Products by Stage and Top 10 Molecule Types, H1 2015 25

Explore more reports on Therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .

Explore more reports of Global Market Direct:-

Poxvirus Infections – Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Poxvirus Infections. Companies discussed in this report include BioApex, s.r.o., China Biologic Products, Inc., SIGA Technologies, Inc. and Takeda Pharmaceutical Company Limited. Complete report with TOC is available @ http://www.rnrmarketresearch.com/poxvirus-infections-pipeline-review-h1-2015-market-report.html .

Arenavirus Infection Lassa Fever – Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Arenavirus Infection Lassa Fever. Companies discussed in this report include Profectus BioSciences, Inc. and SIGA Technologies, Inc. Complete report with TOC is available @ http://www.rnrmarketresearch.com/arenavirus-infection-lassa-fever-pipeline-review-h1-2015-market-report.html .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
Like >
Follow us on
Visit website